Literature DB >> 20559116

An immunohistochemical analysis of pseudomelanocytic nests mimicking melanoma in situ: report of 2 cases.

Kimberly M Nicholson1, Pedram Gerami.   

Abstract

Several case reports have discussed the difficulty in differentiating junctional pseudomelanocytic nests as a result of lichenoid inflammation from a true melanocytic neoplasm. Even immunohistochemistry can be misleading in these cases with both Melan-A and Mart-1 frequently resulting in false positivity as a result of nonspecific labeling of nonmelanocytic cells containing melanosomes. We present a series of 2 similar cases which were initially misdiagnosed as melanoma in situ likely as a result of Mart-1 positivity of the pseudomelanocytic nests. However, in our review, a significant lichenoid reaction was apparent at the dermal-epidermal junction. Staining with microphthalmia-associated transcription factor (MITF) showed a normal density of melanocytes along the dermal-epidermal junction and failed to uniformly label the Mart-1-positive pseudomelanocytic nests. In both patients, medications frequently resulting in fixed drug eruptions were identified, and a final diagnosis of fixed drug eruption was rendered in both cases. In light of these findings we suggest MITF is a more useful marker for evaluating lentiginous proliferations along the dermal-epidermal junction particularly when dealing with the differential diagnosis of lichenoid reaction with pseudomelanocytic nests versus melanoma in situ.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20559116     DOI: 10.1097/DAD.0b013e3181d1537b

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  1 in total

1.  "Melanocytic Nests Arising in Lichenoid Inflammation": Reappraisal of the Terminology "Melanocytic Pseudonests".

Authors:  Hye Jin Chung; A David Simkin; Jag Bhawan; Deon Wolpowitz
Journal:  Am J Dermatopathol       Date:  2015-12       Impact factor: 1.533

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.